×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Myriad Genetics Shares Rise 15% After 1Q Revenue Beats Estimates
MarketWatch
By Chris Wack Myriad Genetics shares were up 15% to $22.66 after the company reported first-quarter revenue that beat analysts' expectations...
15 hours ago
Myriad Genetics (MYGN) Posts Narrower-Than-Estimate Loss in Q1
Yahoo Finance
Myriad Genetics (MYGN) first-quarter average revenue per test across its product portfolio benefited from expanded coverage and ongoing...
16 hours ago
Earnings call: Myriad Genetics posts strong Q1 with revenue growth
Investing.com
Myriad Genetics (NASDAQ:MYGN), a leading player in genetic testing and precision medicine, has reported a robust first quarter with a 12%...
10 hours ago
5-Star Stocks Poised to Pop: Myriad Genetics
AOL.com
Based on the aggregated intelligence of 180000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, molecular diagnostic...
9 hours ago
Myriad Genetics Announces Reorganization of European Operations and Sale of EndoPredict Business
GlobeNewswire
SALT LAKE CITY, May 07, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine,...
1 day ago
Myriad Genetics surges 17% as Street applauds 2024 guidance, Q1 results
Seeking Alpha
Myriad Genetics (MYGN) jumps 17% as Q1 results beat expectations and 2024 guidance impresses with projected revenue growth and adjusted EPS.
17 hours ago
Myriad Genetics Reports Strong First Quarter 2024 Financial Results; Achieves 12% Revenue ...
Bakersfield.com
Myriad Genetics Reports Strong First Quarter 2024 Financial Results; Achieves 12% Revenue ... Myriad Genetics, Inc. - (GLOBE NEWSWIRE)...
1 day ago
Myriad Genetics, Inc. (NASDAQ:MYGN) Q1 2024 Earnings Call Transcript
Insider Monkey
Operator: Thank you for standing by, and welcome to Myriad Genetics First Quarter 2024 Earnings Conference Call.
12 hours ago
Myriad Genetics Reports Q1 2024 Earnings: Revenue Growth Surpasses Estimates Amidst Challenges
Yahoo Finance
Significant Revenue Increase and Improved Losses Highlight Myriad Genetics' First Quarter Performance.
1 day ago
Myriad Genetics (NASDAQ:MYGN) Releases FY 2024 Earnings Guidance
MarketBeat
Myriad Genetics (NASDAQ:MYGN) updated its FY 2024 earnings guidance. The company provided EPS guidance of 0.000-0.050 for the period,...
10 hours ago